{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:00:11Z","timestamp":1785859211905,"version":"3.56.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.msard.2020.101936","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T02:20:05Z","timestamp":1579141205000},"page":"101936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Emergence of rheumatoid arthritis following exposure to natalizumab"],"prefix":"10.1016","volume":"40","author":[{"given":"Elaine","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Novic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May H.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2020.101936_bib0004","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/1352458515623862","article-title":"MS Arising During Tocilizumab Therapy for Rheumatoid Arthritis","volume":"22","author":"Beauchemin","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2020.101936_bib0006","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple Sclerosis - the Plaque and Its Pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2020.101936_bib0007","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/ket414","article-title":"Rheumatoid Arthritis Pathophysiology: Update on Emerging Cytokine and Cytokine-Associated Cell Targets","volume":"53","author":"Furst","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.msard.2020.101936_bib0003","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1212\/01.wnl.0000406608.85830.82","article-title":"TNF Neutralization in MS: Results of a Randomized, Placebo-Controlled Multicenter Study","volume":"77","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.101936_bib0011","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1084\/jem.20140540","article-title":"VLA-4 Blockade Promotes Differential Routes into Human CNS Involving PSGL-1 Rolling of T Cells and MCAM-Adhesion of TH17 Cells","volume":"211","author":"Schneider-Hohendorf","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.msard.2020.101936_bib0005","first-page":"1027","article-title":"Association of Rheumatoid Arthritis with Multiple Sclerosis: Report of 14 Cases and Discussion of Its Significance","volume":"33","author":"Toussirot","year":"2006","journal-title":"J. Rheumatol."},{"issue":"26","key":"10.1016\/j.msard.2020.101936_bib0002","doi-asserted-by":"crossref","first-page":"e3999","DOI":"10.1097\/MD.0000000000003999","article-title":"Increased Incidence of Rheumatoid Arthritis in Multiple Sclerosis: A Nationwide Cohort Study","volume":"95","author":"Tseng","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.msard.2020.101936_bib0009","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.matbio.2014.08.007","article-title":"Integrins and Chondrocyte-Matrix Interactions in Articular Cartilage","volume":"39","author":"Loeser","year":"2014","journal-title":"Matrix Biol"},{"key":"10.1016\/j.msard.2020.101936_bib0008","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/archneur.65.5.656","article-title":"Allergic and Nonallergic Delayed Infusion Reactions during Natalizumab Therapy","volume":"65","author":"Hellwig","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2020.101936_bib0001","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/1352458510369146","article-title":"Autoimmune Diseases Prior to the Diagnosis of Multiple Sclerosis: A Population-Based Case-Control Study","volume":"16","author":"Langer-Gould","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2020.101936_bib0010","unstructured":"ClinicalTrials.gov.Identifier NCT00083759 Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate, ClinicalTrials.gov [Internet] (2016)."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820300122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820300122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:48:20Z","timestamp":1761900500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820300122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":11,"alternative-id":["S2211034820300122"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.101936","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of rheumatoid arthritis following exposure to natalizumab","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.101936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101936"}}